Technology Foresight & Strategy For The Health Biotech And Biopharmaceutical Industry In Chongqing

The pharmaceutical and health biotech industry is called a sun rise industry in the 21 century, which is of most potential of development and international competitiveness. It is a strategic industry on the priority list of many countries and many regions in China. Located in the west of China, Chongqing is a city short of resources. Making a regional development strategy of health biotech and biopharmaceutical industry is of crucial importance and great meaning to the successful development of the health biotech and biopharmaceutical industry of Chongqing.Through the whole procedure of Evaluation, Forecasting, Selection, R & D Possibilities, Difficulty Level of Industrialization, Re-selection and Development, a new mode of regional development strategy was formulated by referring to the practical situation of S & T, economic and social development. Based on the analysis of the international, national and local development status, trend and rule of the health biotech and biopharmaceutical industry, combined with the related theories and models of regional competition, the regional competitiveness of the health biotech and biopharmaceutical industry in Chongqing was discussed by means of parent and literature metrology, technical innovation index, and location quotient analysis, etc. An optional system of health biotech and biopharmaceutical technical foresight was then determined and evaluated through statistical analysis, fuzzy clustering analysis and SWOT analysis. Finally, a regional development strategy of health biotech and biopharmaceutical industry was brought forward.Results of analysis on competitiveness: The health biotech and biopharmaceutical industry in Chongqing hasn't formed its international competitiveness. It has comparatively strong S&T competitiveness in research fields like vaccine, tissue engineering, stem cells and monoclonal antibody, while has an innovative ability at moderate level with an index of 15.24, which is below the national average featuring low input but high output for innovation. From the perspective of industrial agglomeration degree, the health biotech and biopharmaceutical industrial cluster functions of Chongqing has begun to take shape, which has the most considerable advantage among the hi-tech industries of the region.Results of technical foresight: The vaccines for the major infections of AIDS, hepatitis and bird flu, etc; the therapeutic vaccines for major diseases; the antibody pharmacy for major diseases of cardiovascular disease, immune disease or diabetes; the technology platform for monoclonal antibody production; the preparation techniques for raw materials of the natural medicine; the screening platform for drug target; the gene therapy of tumor; the technology for ultrasound therapy and the R&D of facilities; the new vaccine adjuvants and the delivery systems; the transplants and the transplant techniques for autologous, allogeneic, heterologous tissue, all of which are the major concerns in the economic growth and the formation of competitiveness of the health biotech and biopharmaceutical industry in Chongqing and the urban development of the city. Among the listed, the following areas are easier to industrialize: the preparation techniques for raw materials of the natural medicine; the vaccines for the major infections of AIDS, hepatitis and bird flu, etc; the clinical diagnostic reagents of antibody-based biomarker; the R&D of rapid diagnosis reagents for infections; the technology for ultrasound therapy and the R&D of facilities. The cluster analyses of priority and workability show that the priority areas of the health biotech and biopharmaceutical industry in Chongqing lay in four areas including the vaccines for the major infections of AIDS, hepatitis and bird flu, etc; the preparation techniques for raw materials of the natural medicine; the R&D of rapid diagnosis reagents for infections and the clinical diagnostic reagents of antibody-based biomarker.The modes of the development strategy of the health biotech and biopharmaceutical industry in Chongqing vary in view of the different status quo of the advantages and disadvantages, opportunities and challenges, such as seeking optimal portfolio to achieve competitiveness; providing resources for strengthening and extending competitiveness; restructuring organizations to obtain competitiveness and turning challenges into opportunities; adopting defensive strategies to seize most potential opportunities; increasing input in science, trying to improve creativity, promoting integration of production, study and research and turning disadvantages into advantages to explore opportunities; promoting strategic research, identifying the priorities of development, innovating the development modes to minimize the negative effects of the disadvantages and challenges.